Brandl Talos advised a syndicate of the 42CAP, Amino Collective, Push Ventures, Air Street Capital, and VP Venture Partners funds on their investment in Allcyte. Germany's SMP law firm advised the 42CAP fund on its participation. Herbst Kinsky advised Allcyte.
Allcyte is an Austrian biotech firm focused on functional drug testing in primary human material.
Brandl Talos's team was led by Partner Roman Rericha and Attorney Stephan Strass, and included Senior Associate Sonam Schima and Associate Elena Ciresa.
SMP's team was led by Associated Partner Frederik Gartner.
The Herbst Kinsky team was led by Partner Philipp Kinsky and Attorney At Law Carl Walderdorff.